112 related articles for article (PubMed ID: 10893965)
1. [Effectiveness also in general practice conditions. Just as good in routine practice as in studies].
MMW Fortschr Med; 2000; 142(3 Suppl):36-7. PubMed ID: 10893965
[No Abstract] [Full Text] [Related]
2. Nevirapine in children.
Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366500
[TBL] [Abstract][Full Text] [Related]
3. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
[No Abstract] [Full Text] [Related]
4. [Non-nucleoside reverse transcriptase inhibitors. First line therapy].
MMW Fortschr Med; 2000; 142(3 Suppl):34-5. PubMed ID: 10893964
[No Abstract] [Full Text] [Related]
5. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
[No Abstract] [Full Text] [Related]
6. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
Raffi F; Lewden C; Chêne G
AIDS; 2008 Jan; 22(3):435-6. PubMed ID: 18195573
[No Abstract] [Full Text] [Related]
7. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B
Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868
[TBL] [Abstract][Full Text] [Related]
8. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Koh MT
Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
[No Abstract] [Full Text] [Related]
9. Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature.
Cattelan AM; Trevenzoli M; Sasset L; Sgarabotto D; Lanzafame M; Meneghetti F
J Infect; 2001 Nov; 43(4):246-9. PubMed ID: 11869062
[TBL] [Abstract][Full Text] [Related]
10. Nonnucleoside reverse transcriptase inhibitors.
Murphy RL
AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
[TBL] [Abstract][Full Text] [Related]
11. Understanding the reverse transcriptase inhibitors in HIV.
Edmonds-Ogbuokiri J
Fac Notes (New Orleans La); 1998; 10(6):13-5. PubMed ID: 11366142
[TBL] [Abstract][Full Text] [Related]
12. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
[No Abstract] [Full Text] [Related]
13. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
[TBL] [Abstract][Full Text] [Related]
14. Nevirapine (Viramune).
Res Initiat Treat Action; 2000 Mar; 6(1):18-9. PubMed ID: 11708179
[No Abstract] [Full Text] [Related]
15. Switch study of nevirapine.
AIDS Patient Care STDS; 2000 Dec; 14(12):672. PubMed ID: 11187109
[No Abstract] [Full Text] [Related]
16. A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
Kirk O; Lundgren JD; Pedersen C; Mathiesen LR; Nielsen H; Katzenstein TL; Obel N; Gerstoft J
Antivir Ther; 2003 Dec; 8(6):595-602. PubMed ID: 14760893
[TBL] [Abstract][Full Text] [Related]
17. High incidence of nevirapine-associated rash in HIV-infected Chinese.
Ho TT; Wong KH; Chan KC; Lee SS
AIDS; 1998 Oct; 12(15):2082-3. PubMed ID: 9814883
[No Abstract] [Full Text] [Related]
18. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
[TBL] [Abstract][Full Text] [Related]
19. Gender difference in Nevirapine-associated rash.
Proj Inf Perspect; 1999 Apr; (27):11. PubMed ID: 11366728
[TBL] [Abstract][Full Text] [Related]
20. Nevirapine-based fixed-dose combination ARVs.
Meldrum J
GMHC Treat Issues; 2003 May; 17(5):5-9. PubMed ID: 12846176
[No Abstract] [Full Text] [Related]
[Next] [New Search]